Member Info for Kisp57

.....this is materially undervalued. Despite the rather childish discussion,they agree that"all the elements are in place for this to go much higher". None of the wearables,immutex or prepbio elements were mentioned either. An interesting aside was that if ORPH applied for a dual US listing,this could propel the price given generally higher Nasdaq biotech valuations.

Time to top up at these levels. With volatility likely to remain high through this crisis, IGG will be throwing off a lot of cash with the result either substantial dividend rises next year and/or a special.

I would be very surprised if 16p wasn't the new floor. Imo this is a golden opportunity to buy/top up before it goes towards 50p over the next 3 months. I have topped up today to take my holding to 250k shares,my second largest behind VLE. I am expecting this to become a £500m company next year. With all the potential elements that will be auctioned off to the highest bidder (i.e. wearables,prepbio,immutex) you would be shortsighted to give away your shares now.

Many institutional buyers won't even consider or may be prohibited from buying into companies with market caps below £100m. Once we head north of 15p,I believe buyers will push this to higher levels. AIMHO

A bargain in a very unloved sector. Having just rebased the divi,v unlikely to cut again. I still prefer BATS now on an 8% yield for its better product mix. Analysts think IMB a better buy ATM.

An opportunity to top up at below NAV has presented itself as a no brainer for those with cash. Fill yer boots. Real value here at least 1800 imho.

Interesting tenbagger. It makes a lot of sense. Expect CF will be all over this. ORPH looks a no brainer multi bagger,and a punt here may prove fruitful too.

Don't think CF will be thrilled by her shooting her mouth off. It all looks v unprofessional at a critical time for our company. She needs to look for alternative employment imo.

Snap,just posted same.

Jonathan Van Tan just said there were 2 potential 100% reliable tests,one of which is Roche. Quotient's could be the other
one. Grant Shapps just said they weren't just looking at Roche.

I certainly won't be cutting my stake when there is so much going for Orph,with the possible bonus of a stake in Imutex. Indeed will be looking to increase if the price doesn't fly away this week.

Yes,referring to Swinger. Don't understand the mentality of reducing ones stake at the same time as extolling the virtues of said company.

So why would you sell any of your stake in such an exciting company? Excuse me,but it doesn't make sense

Dividends paid in other currencies always take time to hit our accounts. HL also not yet paid out,expect in next few days.

Thank you scoredagain. That was very useful.

Entirely agree cheapshares. IGG is the highest quality spread better with a solid divi that won't be cut,unlike almost everything else. The other safe bets are the tobaccos. I wouldn't touch banks or insurers until we are much further down.

Thank you rivaldo,some welcome good news in this,my largest holding by far.

I managed to get sight of Graham's comments at last. Nothing new,other than it is 20% of his portfolio now. He backs management because of their incredible restraint. The Indulgence acquisition is the first for 5 years,despite having oodles of cash. Opportunism and a focus on capital preservation are two rare and invaluable characteristics of this company. VLE is only risking £1.25m of the cash pile plus a working capital facility,and will presumably look for synergies with Shire. He says he will continue to hold. And in this febrile market,it looks as good a bet as anything!! That last is my own assessment. I now hold over £40k worth for the record.

With the share price a fraction of what it was before the Muddy waters attack, is this another one likely to go the way of Quindell and NMC? Once the subject of negative inuendo and concerted shorting, it seems full recovery is rare. Personally, I continue to hold but am not convinced by management.

As a matter of interest Sara,what's your target to buy here?